# Neurogene Inc.: filings

NGNE · Nasdaq · CIK 1404644 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ngne.md) · [Financials](/companies/ngne/financials.md) · [Filings](/companies/ngne/filings.md) · [Insiders](/companies/ngne/insiders.md)

## Reports and events: 240 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 221, 8-K 148, 3 42, 10-Q 38, SC 13G 33, SC 13G/A 32, SC 13D/A 17, CORRESP 14, S-8 14, 424B5 13, DEFA14A 13, 10-K 12, DEF 14A 12, SCHEDULE 13G/A 12, EFFECT 11, UPLOAD 10, 144 8, S-3 7, 425 6, 4/A 5, ARS 5, D 5, 8-K/A 4, SC 13D 4, SCHEDULE 13G 4, 424B3 3, 5 3, S-4/A 3, 3/A 2, CT ORDER 2, PRE 14A 2, S-1 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, NT 10-Q 1, POS AM 1, POS EX 1, REGDEX/A 1, S-1/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 20:57 ET | [10-Q](/filings/0001404644-26-000059.md) | Quarterly report, period 2026-06-30 | 0001404644-26-000059 |
| 2026-08-11 | 11:32 ET | [8-K](/filings/0001404644-26-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000056 |
| 2026-07-02 | 00:02 ET | [8-K](/filings/0001404644-26-000050.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-26-000050 |
| 2026-06-29 | 12:00 ET | [8-K](/filings/0001404644-26-000046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-26-000046 |
| 2026-06-08 | 11:32 ET | [8-K](/filings/0001404644-26-000044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000044 |
| 2026-06-04 | 20:41 ET | [8-K](/filings/0001404644-26-000040.md) | 5.07 Shareholder vote results | 0001404644-26-000040 |
| 2026-05-12 | 20:06 ET | [8-K](/filings/0001404644-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000038 |
| 2026-05-12 | 20:04 ET | [10-Q](/filings/0001404644-26-000037.md) | Quarterly report, period 2026-03-31 | 0001404644-26-000037 |
| 2026-04-20 | 11:32 ET | [8-K](/filings/0001404644-26-000030.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000030 |
| 2026-04-16 | 20:15 ET | [DEF 14A](/filings/0001404644-26-000027.md) | Proxy statement, period 2026-06-03 | 0001404644-26-000027 |
| 2026-03-24 | 20:04 ET | [10-K](/filings/0001404644-26-000019.md) | Annual report, period 2025-12-31 | 0001404644-26-000019 |
| 2026-03-24 | 11:31 ET | [8-K](/filings/0001404644-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-26-000012 |
| 2026-02-26 | 21:02 ET | [8-K](/filings/0001404644-26-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000006 |
| 2026-01-12 | 12:00 ET | [8-K](/filings/0001404644-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-26-000003 |
| 2025-11-13 | 22:11 ET | [8-K](/filings/0001404644-25-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000103 |
| 2025-11-13 | 21:55 ET | [10-Q](/filings/0001404644-25-000101.md) | Quarterly report, period 2025-09-30 | 0001404644-25-000101 |
| 2025-11-12 | 22:11 ET | [8-K](/filings/0001404644-25-000098.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000098 |
| 2025-11-06 | 12:31 ET | [8-K](/filings/0001404644-25-000091.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000091 |
| 2025-10-09 | 11:01 ET | [8-K](/filings/0001404644-25-000088.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000088 |
| 2025-08-11 | 20:08 ET | [8-K](/filings/0001404644-25-000082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000082 |
| 2025-08-11 | 20:05 ET | [10-Q](/filings/0001404644-25-000081.md) | Quarterly report, period 2025-06-30 | 0001404644-25-000081 |
| 2025-06-30 | 20:02 ET | [8-K](/filings/0001404644-25-000070.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000070 |
| 2025-06-12 | 20:20 ET | [8-K](/filings/0001404644-25-000053.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001404644-25-000053 |
| 2025-06-09 | 11:25 ET | [8-K](/filings/0001404644-25-000049.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-25-000049 |
| 2025-05-09 | 11:30 ET | [8-K](/filings/0001404644-25-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000044 |
| 2025-05-09 | 11:19 ET | [10-Q](/filings/0001404644-25-000041.md) | Quarterly report, period 2025-03-31 | 0001404644-25-000041 |
| 2025-04-25 | 13:53 ET | [DEF 14A](/filings/0001404644-25-000034.md) | Proxy statement, period 2025-04-25 | 0001404644-25-000034 |
| 2025-04-14 | 20:50 ET | [8-K](/filings/0001404644-25-000029.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001404644-25-000029 |
| 2025-03-24 | 20:14 ET | [8-K](/filings/0001404644-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-25-000014 |
| 2025-03-24 | 20:04 ET | [10-K](/filings/0001404644-25-000012.md) | Annual report, period 2024-12-31 | 0001404644-25-000012 |
| 2025-01-13 | 12:30 ET | [8-K](/filings/0001404644-25-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-25-000004 |
| 2024-12-02 | 22:27 ET | [S-1](/filings/0001628280-24-049615.md) | Registration statement | 0001628280-24-049615 |
| 2024-11-21 | 21:01 ET | [8-K](/filings/0001404644-24-000109.md) | 7.01 Regulation FD disclosure | 0001404644-24-000109 |
| 2024-11-18 | 22:27 ET | [10-Q](/filings/0001404644-24-000104.md) | Quarterly report, period 2024-09-30 | 0001404644-24-000104 |
| 2024-11-18 | 22:26 ET | [8-K](/filings/0001404644-24-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000103 |
| 2024-11-18 | 11:50 ET | [8-K](/filings/0001404644-24-000097.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000097 |
| 2024-11-12 | 11:05 ET | [8-K](/filings/0001404644-24-000091.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000091 |
| 2024-11-04 | 12:33 ET | [8-K](/filings/0001404644-24-000089.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000089 |
| 2024-08-09 | 20:15 ET | [10-Q](/filings/0001404644-24-000086.md) | Quarterly report, period 2024-06-30 | 0001404644-24-000086 |
| 2024-08-09 | 11:31 ET | [8-K](/filings/0001404644-24-000085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000085 |
| 2024-08-07 | 11:31 ET | [8-K](/filings/0001404644-24-000083.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000083 |
| 2024-06-21 | 12:32 ET | [8-K](/filings/0001404644-24-000080.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000080 |
| 2024-06-18 | 18:11 ET | [8-K](/filings/0001404644-24-000073.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000073 |
| 2024-06-17 | 18:35 ET | [8-K](/filings/0001404644-24-000066.md) | 5.07 Shareholder vote results | 0001404644-24-000066 |
| 2024-06-03 | 11:31 ET | [8-K](/filings/0001404644-24-000059.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000059 |
| 2024-05-10 | 20:14 ET | [10-Q](/filings/0001404644-24-000057.md) | Quarterly report, period 2024-03-31 | 0001404644-24-000057 |
| 2024-05-10 | 11:31 ET | [8-K](/filings/0001404644-24-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001404644-24-000054 |
| 2024-05-07 | 10:20 ET | [8-K](/filings/0001404644-24-000049.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001404644-24-000049 |
| 2024-04-26 | 18:33 ET | [DEF 14A](/filings/0001404644-24-000043.md) | Proxy statement, period 2024-04-26 | 0001404644-24-000043 |
| 2024-04-25 | 21:47 ET | [8-K](/filings/0001404644-24-000041.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001404644-24-000041 |

Page 1 of 5. [Older](/companies/ngne/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.